White label – Pompe disease - ClinicalTrials.eu

Study on Tralokinumab and Topical Corticosteroids for Children and Infants with Moderate-to-Severe Atopic Dermatitis

Not recruiting

4 1 1
Investigated Drugs:
- Tralokinumab
+6
Study on the Effectiveness and Safety of Durvalumab and Olaparib for Patients with Stage IV Non-Small Cell Lung Cancer After Initial Chemotherapy

Not recruiting

2 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
- Durvalumab
- Olaparib
Study on Glenzocimab for Patients with Acute Ischemic Stroke Undergoing Mechanical Thrombectomy

Not recruiting

4 1
Investigated Diseases:
- Ischaemic stroke
Investigated Drugs:
- Glenzocimab
Study on Esflurbiprofen and Paracetamol for Pain Relief in Patients with Limb Bruises

Not recruiting

3 1 1 1
Investigated Diseases:
- Contusion
Investigated Drugs:
- Esflurbiprofen
- Paracetamol
Study on Obinutuzumab and Rituximab with Chemotherapy for Adults with Newly Diagnosed CD20-Positive Acute Lymphoblastic Leukemia

Not recruiting

2 1 1 1
Investigated Diseases:
- Acute lymphocytic leukaemia
Investigated Drugs:
- Obinutuzumab
- Rituximab
Study of SPI-62 for Treating Cushing’s Syndrome in Patients with Benign Adrenal Tumors

Not recruiting

2 1 1
Investigated Diseases:
- Hyperadrenocorticism
Investigated Drugs:
- 4-{5-[2-(4-Chloro-2,6-Difluorophenoxy)Propan-2-Yl]-4-Methyl-4H-1,2,4-Triazol-3-Yl}-3-Fluorobenzamide
Study to Evaluate Plozasiran for Adults with High Triglycerides

Not recruiting

3 1
Investigated Diseases:
- Hypertriglyceridaemia
Investigated Drugs:
- Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
+3
Study on Long-term Safety of Satoreotide Tetraxetan Lutetium-177 for Patients with Somatostatin Receptor Positive Neuroendocrine Tumors

Not recruiting

3 1 1
Investigated Diseases:
- Neuroendocrine tumour
Investigated Drugs:
- Satoreotide Tetraxetan
- Satoreotide Tetraxetan Lutetium-177
Study on Venetoclax, Azacitidine, and Donor Lymphocyte Infusion for Patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia Relapse After Transplantation

Not recruiting

1 1 1 1
Investigated Drugs:
- Azacitidine
- Venetoclax
Study of Mitapivat for Patients with Sickle Cell Disease and Kidney Disease

Not recruiting

2 1 1
Investigated Diseases:
- Sickle cell disease
Investigated Drugs:
- Mitapivat

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies